Related Experiment Video

Updated: Aug 3, 2026

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

Septicaemia in newborns and infants

O Pettay

    Scandinavian Journal of Infectious Diseases. Supplementum
    |January 1, 1982
    PubMed

    Insights

    Neonatal and childhood septicaemia result from immature immune systems, with changing bacterial causes over 20 years. Effective treatment requires more than antibiotics, including transfusions, due to rising antimicrobial resistance.

    Area of Science:

    • Pediatrics
    • Infectious Diseases
    • Immunology

    Background:

    • Neonates and the elderly are susceptible to septicaemia due to underdeveloped or declining immune defenses.
    • Immune mechanisms in newborns are present but lack experience in combating infections.

    Observation:

    • Etiologic agents causing nursery septicaemia have evolved over two decades, shifting from staphylococci to Gram-negative rods, then Group B streptococci.
    • Current challenges include increasing hospital-acquired infections and evolving bacterial resistance patterns.

    Findings:

    • Septicaemia in infants presents distinct clinical pictures compared to newborns and adults.
    • Antibiotic monotherapy is insufficient for treating neonatal and infant septicaemia.
    • Treatment necessitates advanced interventions such as exchange transfusions and granulocyte transfusions.

    Implications:

    • The changing landscape of bacterial pathogens and antimicrobial resistance requires reassessment of therapeutic strategies for pediatric septicaemia.
    • Understanding shifts in etiology is crucial for developing targeted prevention and treatment protocols.
    • Further research into immune system development and novel therapeutic approaches is warranted.

    More Related Videos

    A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis08:46

    A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

    Published on: August 12, 2020

    Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates08:32

    Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates

    Published on: February 17, 2023

    Related Concept Videos

    Development of Human Microbiota01:30

    Development of Human Microbiota

    The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
    Development of the Oral Microbiota01:28

    Development of the Oral Microbiota

    The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
    Bacterial Meningitis01:24

    Bacterial Meningitis

    Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
    Viral Meningitis01:18

    Viral Meningitis

    Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
    Bacterial Meningitis I: Introduction01:22

    Bacterial Meningitis I: Introduction

    Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
    Bacterial Meningitis II: Pathophysiology01:26

    Bacterial Meningitis II: Pathophysiology

    Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...